Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Mounjaro 'Magical' Until Pancreas Began Dying: Patient - Featured image
GLP-1 Medications

Mounjaro 'Magical' Until Pancreas Began Dying: Patient

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 21, 2026·3 min read

On this page

  • Mounjaro Success Turns to Nightmare
  • Diagnosis: Pancreatitis and Pancreatic Necrosis
  • Symptoms and Hospital Struggles
  • Regrets and Life on Hold
  • What is Pancreatic Necrosis?
  • Lilly's Statement on Mounjaro Safety
  • Alisha's Warning for Mounjaro Users

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Alisha Trafford called Mounjaro 'magical' after dropping 3.5 stone and easing PCOS symptoms. But intense pain led to hospitalizations for pancreatitis and pancreatic necrosis, linked by doctors to the drug. She warns others to monitor symptoms closely.

Share

On this page

  • Mounjaro Success Turns to Nightmare
  • Diagnosis: Pancreatitis and Pancreatic Necrosis
  • Symptoms and Hospital Struggles
  • Regrets and Life on Hold
  • What is Pancreatic Necrosis?
  • Lilly's Statement on Mounjaro Safety
  • Alisha's Warning for Mounjaro Users

Mounjaro Success Turns to Nightmare

Alisha Trafford, a 25-year-old healthcare assistant from Hull, hailed Mounjaro (tirzepatide) as 'magical' when she started it in February 2025. She purchased the £135 injection from an online pharmacy to lose weight and manage painful PCOS symptoms. In three months, she shed an impressive three-and-a-half stone.

Everything changed on May 28, 2025. Alisha experienced intense abdominal pain and vomiting, leading to an emergency hospital visit.

Diagnosis: Pancreatitis and Pancreatic Necrosis

Doctors diagnosed Alisha with pancreatitis, reportedly caused by Mounjaro. She endured multiple hospital admissions over the following months, with only brief respites between stays.

Further tests revealed pancreatic necrosis, where pancreas tissue dies due to lost blood supply. This serious complication can lead to infection, sepsis, and potentially fatal outcomes if untreated.

Alisha stopped Mounjaro after her first admission. Despite treatment with fluids and painkillers, she lost two stone in hospital from inability to eat. Her consultant attributed it firmly to the medication.

Symptoms and Hospital Struggles

Alisha described the pain as excruciating, mimicking a heart attack. After her initial week-long stay, she was readmitted within 48 hours.

  • Agonizing pain prevented her from lifting her head or speaking.
  • Exhaustion left her sleeping most of the time.
  • Multiple admissions from May to August 2025 stunned her consultant, who noted her youth spared her a medically induced coma.

She faced another pancreatitis episode on December 6, 2025, and now lives with lifelong risk of recurrence.

Regrets and Life on Hold

Alisha says Mounjaro initially transformed her life, outperforming past weight loss attempts and improving PCOS. But now, her life is 'on hold.'

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play
'If I knew this was what my life was going to be like then I never would have taken it,' Alisha said. 'I was independent and healthy; now I'm at constant risk.'

She's shifted to natural weight loss methods and urges caution.

What is Pancreatic Necrosis?

Per the NHS, pancreatitis involves short-term pancreas inflammation. Pancreatic necrosis occurs in severe cases when blood supply fails, causing tissue death.

  • Tissue death can lead to infection.
  • This risks sepsis and organ failure.
  • Untreated, it can be fatal.

Lilly's Statement on Mounjaro Safety

Lilly, manufacturer of Mounjaro, emphasizes patient safety as their top priority. They monitor and report safety data actively.

The Mounjaro Patient Information Leaflet lists acute pancreatitis as an uncommon side effect (up to 1 in 100 people). It advises consulting a doctor if there's prior pancreatitis history and to report side effects.

Patients should ensure they use genuine Lilly medicine and seek professional advice for any issues.

Alisha's Warning for Mounjaro Users

Alisha advises: 'Don't ignore pain. If something feels wrong, get it checked—it's not worth the risk.'

Those on GLP-1 medications like Mounjaro should monitor for abdominal pain, vomiting, or unusual symptoms promptly.

Source Information

Originally published by Belfast Live.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Beyond the Scale: GLP-1 Users & the Exercise Paradox
Health & Wellness

Beyond the Scale: GLP-1 Users & the Exercise Paradox

While GLP-1 medications have revolutionized weight loss, a recent study indicates a concerning trend: users may be reducing their physical activity. This article explores the findings and emphasizes the continued importance of exercise.

7 min read
Ozempic, Wegovy & Mounjaro: Navigating Dizziness and Fainting Risks
Health & Wellness

Ozempic, Wegovy & Mounjaro: Navigating Dizziness and Fainting Risks

Recent research highlights a potential safety concern with GLP-1 medications, linking them to an increased risk of dizziness and fainting, particularly in certain patient groups. Discover what this means for your health.

6 min read
GLP-1s & Telehealth: Navigating Risks and Ensuring Safety
Health & Wellness

GLP-1s & Telehealth: Navigating Risks and Ensuring Safety

The booming popularity of GLP-1 medications for weight loss has coincided with a dramatic rise in telehealth services. This article delves into the benefits and significant risks of obtaining these powerful drugs online, highlighting critical safety concerns and offering guidance for patients.

6 min read

Same topic: Mounjaro

All Mounjaro articles →
Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients
Pharmaceutical Policy & Access

Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients

Eli Lilly Australia has announced that Mounjaro (tirzepatide) will not be listed on the Pharmaceutical Benefits Scheme (PBS) for Type 2 Diabetes, citing unsustainable funding conditions. This decision highlights ongoing challenges in accessing modern GLP-1 and GIP therapies.

6 min read
Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business
GLP-1 Medications

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business

Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.

5 min read
Mounjaro Face Effect: Causes and Prevention Tips
GLP-1 Medications

Mounjaro Face Effect: Causes and Prevention Tips

The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.

6 min read

More in GLP-1 Medications

Ozempic, Wegovy & Beyond: How GLP-1 Drugs Are Changing What We Eat
Health & Wellness

Ozempic, Wegovy & Beyond: How GLP-1 Drugs Are Changing What We Eat

The rise of GLP-1 medications is profoundly altering consumer spending habits and food preferences, forcing the grocery industry to adapt. Discover the science behind these changes and how businesses are responding.

7 min read
Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy
Health & Wellness

Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy

While BMI is a primary factor, a range of underlying health conditions and personal histories can lead to a doctor declining a prescription for popular weight loss medications like Mounjaro and Wegovy. Understanding these criteria is vital before seeking treatment.

7 min read
Share this article
  1. Home
  2. Blog
  3. Mounjaro 'Magical' Until Pancreas Began Dying: Patient
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community